Stepwise treatment is the best way to manage solar urticaria, a rare but disabling photodermatosis mediated by immunoglobulin E (IgE), according to a systematic review and meta-analysis in the Journal of Clinical Medicine .
A group led by Maya Engler Markowitz, MD, a dermatologist at Rabin Medical Center in Petah Tikva, Israel, concluded that therapy should begin with high-dose H1 antihistamines, with the addition of leukotriene receptor antagonists if necessary. If these are ineffective, the next steps are phototherapy and immunotherapy with a biologic.
Though its exact prevalence is unknown — a recent study found its occurrence to be rising in the US, particularly in children. Solar urticaria can significantly impair quality of life and severely limit daily activities. It is esti